Skip to content

About Fidelis Animal Health

We are a commercial stage company with an extensive pipeline utilizing our innovative drug delivery technology, Fidelipid LAI.TM 
As experts in the acquisition, development, and marketing of unique pharmaceutical formulations that meet specialized veterinary needs, we are using our extensive experience to bring much-needed pharmaceuticals to market.

Our mission is to upgrade the standard of care for animals large and small with our innovative drug delivery technology, Fidelipid LAI.

We are focused on acquiring and developing products that will bring value-added specialty veterinary pharmaceuticals to the market across multiple treatment areas. This is fulfilling our vision to lead the industry with quality-driven pain management and other innovations using our proprietary extended-release technology.

Fidelis Animal Health is a privately held U.S.-based company serving the world from the Northeast pharmaceutical corridor:

  • Corporate headquarters located in New Jersey.
  • Lead product manufactured in Pennsylvania.
  • Supply chain sources and manufacturing sites and operations are in compliance with current Good Manufacturing Practices (cGMPs) regulated by the FDA.
  • Dedicated to providing pharmaceutical-grade products that are indexed by the FDA.